Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Divya Lenkala

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Plos One|December 16, 2014
Identifying and validating a combined mRNA and microRNA signature in response to imatinib treatment in a chronic myeloid leukemia cell lineSteven Bhutra, Divya Lenkala, Bonnie LaCroix, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 1, 2015
MicroRNA biogenesis and cellular proliferationDivya Lenkala, Eric R Gamazon, Bonnie LaCroix, et al.
Human Genetics|March 11, 2014
The impact of microRNA expression on cellular proliferationDivya Lenkala, Bonnie LaCroix, Eric R Gamazon, et al.
Pharmacogenetics and Genomics|January 8, 2015
Peripheral blood IRF1 expression as a marker for glucocorticoid sensitivityWilliam J Chapin, Divya Lenkala, Yifeng Mai, et al.
BMC Genomics|April 18, 2014
Integrative analyses of genetic variation, epigenetic regulation, and the transcriptome to elucidate the biology of platinum sensitivityBonnie LaCroix, Eric R Gamazon, Divya Lenkala, et al.
Journal of the National Cancer Institute|August 23, 2015
Predicting Response to Histone Deacetylase Inhibitors Using High-Throughput GenomicsPaul Geeleher, Andrey Loboda, Divya Lenkala, et al.
Genome Medicine|August 15, 2020
Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopesAsaf Poran, Dewi Harjanto, Matthew Malloy, et al.
Oncotarget|May 26, 2016
Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patientsGladys Morrison, Divya Lenkala, Bonnie LaCroix, et al.
Plos One|February 13, 2014
Genetic variation is the major determinant of individual differences in leukocyte endothelial adhesionMichael A Grassi, Vidhya Rao, Kathryn P Winkler, et al.
Cell Reports Methods|April 27, 2022
Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutationsJaewon Choi, Scott P Goulding, Brandon P Conn, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Plos One|December 16, 2014
Identifying and validating a combined mRNA and microRNA signature in response to imatinib treatment in a chronic myeloid leukemia cell lineSteven Bhutra, Divya Lenkala, Bonnie LaCroix, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 1, 2015
MicroRNA biogenesis and cellular proliferationDivya Lenkala, Eric R Gamazon, Bonnie LaCroix, et al.
Human Genetics|March 11, 2014
The impact of microRNA expression on cellular proliferationDivya Lenkala, Bonnie LaCroix, Eric R Gamazon, et al.
Pharmacogenetics and Genomics|January 8, 2015
Peripheral blood IRF1 expression as a marker for glucocorticoid sensitivityWilliam J Chapin, Divya Lenkala, Yifeng Mai, et al.
BMC Genomics|April 18, 2014
Integrative analyses of genetic variation, epigenetic regulation, and the transcriptome to elucidate the biology of platinum sensitivityBonnie LaCroix, Eric R Gamazon, Divya Lenkala, et al.
Journal of the National Cancer Institute|August 23, 2015
Predicting Response to Histone Deacetylase Inhibitors Using High-Throughput GenomicsPaul Geeleher, Andrey Loboda, Divya Lenkala, et al.
Genome Medicine|August 15, 2020
Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopesAsaf Poran, Dewi Harjanto, Matthew Malloy, et al.
Oncotarget|May 26, 2016
Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patientsGladys Morrison, Divya Lenkala, Bonnie LaCroix, et al.
Plos One|February 13, 2014
Genetic variation is the major determinant of individual differences in leukocyte endothelial adhesionMichael A Grassi, Vidhya Rao, Kathryn P Winkler, et al.
Cell Reports Methods|April 27, 2022
Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutationsJaewon Choi, Scott P Goulding, Brandon P Conn, et al.
Pageof 2